NGL Fine-Chem Limited (NGLFINE) - Cash Flow Conversion Efficiency
Based on the latest financial reports, NGL Fine-Chem Limited (NGLFINE) has a cash flow conversion efficiency ratio of 0.056x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs167.72 Million ≈ $1.81 Million USD) by net assets (Rs3.00 Billion ≈ $32.47 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see NGL Fine-Chem Limited stock valuation for the company's overall valuation and market capitalisation.
NGL Fine-Chem Limited - Cash Flow Conversion Efficiency Trend (2009–2026)
This chart illustrates how NGL Fine-Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
NGL Fine-Chem Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of NGL Fine-Chem Limited ranked by their cash flow conversion efficiency. Explore how high is NGL Fine-Chem Limited's earnings quality to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Franklin Universal Closed Fund
NYSE:FT
|
0.027x |
|
Nam Kim Steel JSC
VN:NKG
|
0.062x |
|
Lithium Royalty Corp
TO:LIRC
|
-0.001x |
|
XRF Scientific Ltd
AU:XRF
|
0.104x |
|
TerrAscend Corp
F:TED
|
0.081x |
|
SPACSphere Acquisition Corp. Class A Ordinary Shares
NASDAQ:SSAC
|
0.000x |
|
D2L Inc
TO:DTOL
|
-0.196x |
|
Ascom Holding AG
SW:ASCN
|
0.200x |
Annual Cash Flow Conversion Efficiency for NGL Fine-Chem Limited (2009–2026)
The table below shows the annual cash flow conversion efficiency of NGL Fine-Chem Limited from 2009 to 2026. View NGL Fine-Chem Limited stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2026-03-31 | Rs3.29 Billion ≈ $35.60 Million |
Rs395.40 Million ≈ $4.28 Million |
0.120x | -5.31% |
| 2025-03-31 | Rs2.82 Billion ≈ $30.54 Million |
Rs358.22 Million ≈ $3.87 Million |
0.127x | +62.77% |
| 2024-03-31 | Rs2.63 Billion ≈ $28.40 Million |
Rs204.65 Million ≈ $2.21 Million |
0.078x | -50.85% |
| 2023-03-31 | Rs2.23 Billion ≈ $24.07 Million |
Rs352.86 Million ≈ $3.82 Million |
0.159x | +133.07% |
| 2022-03-31 | Rs2.03 Billion ≈ $21.98 Million |
Rs138.25 Million ≈ $1.50 Million |
0.068x | -61.59% |
| 2021-03-31 | Rs1.54 Billion ≈ $16.70 Million |
Rs273.54 Million ≈ $2.96 Million |
0.177x | -14.36% |
| 2020-03-31 | Rs989.61 Million ≈ $10.70 Million |
Rs204.64 Million ≈ $2.21 Million |
0.207x | +115.34% |
| 2019-03-31 | Rs921.23 Million ≈ $9.96 Million |
Rs88.47 Million ≈ $956.76K |
0.096x | -69.07% |
| 2018-03-31 | Rs720.42 Million ≈ $7.79 Million |
Rs223.65 Million ≈ $2.42 Million |
0.310x | +84.86% |
| 2017-03-31 | Rs585.12 Million ≈ $6.33 Million |
Rs98.26 Million ≈ $1.06 Million |
0.168x | -11.71% |
| 2016-03-31 | Rs442.15 Million ≈ $4.78 Million |
Rs84.10 Million ≈ $909.54K |
0.190x | -16.82% |
| 2015-03-31 | Rs328.16 Million ≈ $3.55 Million |
Rs75.04 Million ≈ $811.54K |
0.229x | +1990.49% |
| 2014-03-31 | Rs245.44 Million ≈ $2.65 Million |
Rs-2.97 Million ≈ $-32.11K |
-0.012x | -932.61% |
| 2013-03-31 | Rs200.15 Million ≈ $2.16 Million |
Rs-234.46K ≈ $-2.54K |
-0.001x | -101.43% |
| 2012-03-31 | Rs171.06 Million ≈ $1.85 Million |
Rs14.01 Million ≈ $151.47K |
0.082x | -66.15% |
| 2011-03-31 | Rs160.59 Million ≈ $1.74 Million |
Rs38.85 Million ≈ $420.12K |
0.242x | +140.92% |
| 2010-03-31 | Rs136.48 Million ≈ $1.48 Million |
Rs13.70 Million ≈ $148.20K |
0.100x | +413.97% |
| 2009-03-31 | Rs109.35 Million ≈ $1.18 Million |
Rs-3.50 Million ≈ $-37.82K |
-0.032x | -- |
About NGL Fine-Chem Limited
NGL Fine-Chem Limited manufactures and sells pharmaceuticals and intermediates for usage in veterinary and human health in India, Europe, the Asia Pacific, the United States, and internationally. The company offers animal health pharmaceutical ingredients, such as homidium chloride, nitroxynil, clorsulon, parvaquone, buparvaquone, isometamidium chloride hydrochloride, toldimfos sodium, butaphosph… Read more